CCAR1 and glioblastoma: In our investigation, we identified another regulatory pathway of RUNX1 in GBM, the RUNX1/PDIA5/CCAR1 pathway, and demonstrated its role in promoting the malignant progression of GBM both in vitro and in vivo by regulating the expression of PDIA5.